Search or browse our database of members’ products and services or add your own listing
An Anti-Infectives pharmaceutical company that has developed and patented a portfolio of drugs, which have a completely different mode of action from conventional antibiotics. These compounds have been shown to work in such a way that bacteria are unable to develop resistance to repeated dosing. They can therefore be used to treat and prevent ""Superbugs"" such as methicillin-resistant Staphylococcus aureus (MRSA), one of the major unmet needs of Western medicine.
MRSA biotechnology Staphylococcus aureus light activated bacteria super bug antibiotic pharmaceutical drug clinical CDIF
"Since going live in November 2007, this product has proven to be an incredibly useful working tool." The system was designed in 2007 with experts from UK's NHS and the USA's biotechs. The product gives Local Research Networks the ability to accurately record all accrual data at a site specific, ensuring successful trial support & management, whilst ensuring data integrity. It enables efficiencies and therefore maximises funding for your research.
clinical bio medical trials pharma pharmaceutical research support technology web SaaS internet